Today we announce a new integrated solution with @IBMWatsonHealth, which combines the Aetion Evidence Platform with IBM MarketScan Research Databases data. We’re providing a solution to allow small and mid-sized biopharma to generate regulatory-grade #RWE: https://www.aetion.com/press-release/new-aetion-tool-brings-real-world-evidence-research-to-small-and-mid-sized-pharma-companies …pic.twitter.com/XEXDNECVsg
